A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.
about
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral loadComparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosisChronic hepatitis C and liver fibrosis.Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient dataNoninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis C by EOB-MRI.Non-invasive assessment of liver fibrosis in chronic hepatitis B.Non-invasive diagnosis of hepatitis B virus-related cirrhosisLiver elastography, comments on EFSUMB elastography guidelines 2013.An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver.Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C.Noninvasive tools to assess hepatic fibrosis: ready for prime time?Current status of novel antifibrotic therapies in patients with chronic liver diseaseA brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis.Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers.Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.Role of simple biomarkers in predicting fibrosis progression in HCV infection.Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C.FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.Danoprevir monotherapy decreases inflammatory markers in patients with chronic hepatitis C virus infection.Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease.Prospective pilot study of a single daily dosage of trientine for the treatment of Wilson diseaseValidation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia.Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis.Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarrayUse of transient elastography in patients with HIV-HCV coinfection: A systematic review and meta-analysisClinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis.Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infectionDeveloping a 'traffic light' test with potential for rational early diagnosis of liver fibrosis and cirrhosis in the community.Biomarkers in liver disease: emerging methods and potential applicationsTreatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.FibroMAX: towards a new universal biomarker of liver disease?Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay.Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males
P2860
Q21144283-4009FD6A-6716-4320-869D-D975AAA6D521Q21261905-0AB68B54-9956-4C3B-A924-7A4E606B2F49Q26825671-6648A5DE-A99A-4035-BAB4-45BD746E9B2AQ28481485-7BEA8BA3-AC30-4F79-BE51-43CE8D1DCB3EQ30397191-6E083679-BE08-4FBE-A65E-8B98CB9A3A7BQ30422395-69E0B63A-88AC-44AD-8985-1A612A3356D8Q30427489-6E96DF86-E122-4CA7-9D39-620ED1858D5BQ30442641-9A190716-4B92-400C-B5FA-8563E53D268FQ30448132-F9280CE6-ECA4-4B36-8EA4-0584693643E4Q30453975-98499589-9F71-4880-9464-ECB1F548951BQ30462755-D8F31CAC-A724-489C-BA0B-73AE0BC43194Q30464087-994933A8-98F1-4138-9A70-894BB284623AQ30473375-60C7604F-A6F7-4A66-BAA5-DDDD9FE32FAEQ30476922-0A7575B9-392F-482D-B421-B06652DE81EAQ30484815-FCFB65DB-1E17-4F72-93AB-4FFECB83F29CQ33389189-D9DAC425-543B-49A2-A963-D850F1F38521Q34064042-1DD7F417-C8EF-4D0A-A48D-5CB5FC8865BDQ34385138-BCC3BCC7-A70A-42BB-B37C-1047C831B772Q34476310-63DC96F8-CADF-4886-8B71-2974591296A9Q34686484-BEEABB8B-7143-4C3C-B497-C679FB240144Q34749550-08D7E752-6865-4ABE-BE59-73E4339E6621Q34892910-B6007803-AF7B-475A-B100-2B3619E3C006Q34893571-AEB0695D-5C67-4C53-A780-B01DCFBEA077Q35065912-720E8906-14E9-4ADD-A1A6-02E241C9D69AQ35155090-C86B7914-63FD-4545-8A5A-C4DA5B5D23E4Q35594074-00D391D5-6E19-469B-8050-9C8EAE4DACECQ35625389-25AEA4ED-33B0-40C7-8E76-8F3D47651622Q35785198-F44E5DF8-EBA7-41BE-8CEC-5439DA7EF872Q35945962-CAA5BE2A-6DCB-4B72-BB63-87CD2C0C2F6BQ35948551-07DFE9C5-D4BB-4300-A883-0101599B11E0Q35958287-9E8D89D4-021C-4485-9B85-E3C64C4E5DABQ35981177-C4343C65-0A36-4821-9ACC-8C7D02088269Q36185805-1F72D794-3AB1-4770-A0EE-B5C4792D8B47Q36413685-D94A352E-9994-4AF6-9853-37625EE3552DQ36479541-956249AA-A7A5-4F66-A862-D51D3361569CQ36914350-E2B5D4C9-8CE3-4F79-A951-06174CADCA31Q36950410-6912CCCF-1B34-443F-BF2C-15C5965D9531Q37002423-D88CF7F8-28EC-46ED-9CE0-BBD8FE22647FQ37086216-DF2E57BA-76C5-4B1D-81F3-E9FF3FE64A5CQ37091418-9593148B-C395-4C75-BBFB-645B49ECBBEA
P2860
A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A prospective analysis of the ...... ents with chronic hepatitis C.
@ast
A prospective analysis of the ...... ents with chronic hepatitis C.
@en
A prospective analysis of the prognostic value of biomarkers
@nl
type
label
A prospective analysis of the ...... ents with chronic hepatitis C.
@ast
A prospective analysis of the ...... ents with chronic hepatitis C.
@en
A prospective analysis of the prognostic value of biomarkers
@nl
prefLabel
A prospective analysis of the ...... ents with chronic hepatitis C.
@ast
A prospective analysis of the ...... ents with chronic hepatitis C.
@en
A prospective analysis of the prognostic value of biomarkers
@nl
P2093
P1433
P1476
A prospective analysis of the ...... ents with chronic hepatitis C.
@en
P2093
Djamila Messous
Dominique Thabut
Françoise Imbert-Bismut
Frederic Charlotte
Joseph Moussalli
Mona Munteanu
Pascal Lebray
Vincent Thibault
Vlad Ratziu
P304
P356
10.1373/CLINCHEM.2006.070961
P407
P577
2006-08-24T00:00:00Z